Article
Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in population with MASLD
2026-05-11
Abstract excerpt
<title>Abstract</title> <p> Background The impact of clonal haematopoiesis of indeterminate potential (CHIP), a novel cardiovascular risk factor, remains unclear in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), where cardiovascular disease (CVD) is the main cause of mortality. Methods We analyzed data from 140,086 UK Biobank participants with MASLD. CHIP was identified via who...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7fe17c30-76cb-5681-812c-92aaf1d8fb8c
- DOI
- 10.21203/rs.3.rs-9472445/v1
